Rubric Capital Management LP 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 4:07 pm Sale | 2025-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Rubric Capital Management LP | 3,328,653 7.370% | -581,153 (-14.86%) | Filing |
| 2025-07-09 4:06 pm Purchase | 2025-06-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Rubric Capital Management LP | 3,909,806 9.240% | 526,567 (+15.56%) | Filing |
| 2025-05-14 4:04 pm Purchase | 2025-03-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Rubric Capital Management LP | 3,383,239 8.050% | 964,136 (+39.86%) | Filing |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Rubric Capital Management LP | 2,419,103 5.960% | 2,419,103 (New Position) | Filing |